Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV
about
The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsHistorical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.Griffithsin-Modified Electrospun Fibers as a Delivery Scaffold To Prevent HIV Infection.Tunable Release of Multiclass Anti-HIV Drugs that are Water-Soluble and Loaded at High Drug Content in Polyester Blended Electrospun Fibers.Current strategies for sustaining drug release from electrospun nanofibers.Coaxially electrospun fiber-based microbicides facilitate broadly tunable release of maravirocEvaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Application of electrospun fibers for female reproductive health.An Exploratory Study of Acculturation and Reproductive Health Among Haitian and Haitian-American Women in Little Haiti, South Florida.In vitro-ex vivo correlations between a cell-laden hydrogel and mucosal tissue for screening composite delivery systems.Poly(methyl vinyl ether-alt-maleic acid) and ethyl monoester as building polymers for drug-loadable electrospun nanofibers.Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections.Nanoparticle-releasing nanofiber composites for enhanced in vivo vaginal retention.Harnessing nanostructured systems for improved treatment and prevention of HIV disease
P2860
Q28087336-A8572EA9-5396-480D-98B5-823381D13D2DQ33821090-43370A16-066D-4E80-B311-077C7AB4EF30Q35960654-00AE2AC6-9AD5-47ED-A1D5-E89CF5F32819Q37358616-9BB4CF5E-5DDC-4B1F-BD55-273EB3372150Q37565913-DABBC17B-CB25-4F7E-9557-2399D9DE64D2Q37585816-A5C83DCD-D999-42C6-8953-6F8404CC48D5Q38781199-598A0F56-B99A-44A4-BFF6-8B02920BAF85Q39063908-32EC9ED8-F560-4D47-BE44-5707675A0CB0Q39301728-AC0266EE-DA76-47A3-948F-538CB70DF2E1Q41152568-EDE068A4-50BE-4388-A39B-09D39928842DQ42745529-5C07ADFD-3021-4A29-B495-82EDF3BBCF47Q47100730-41DB1C8F-7266-48C7-B468-3BE65BACB316Q47384815-6483DC8C-891C-442F-A25B-B3CC0AD4B29DQ47930607-AF018A9E-F207-4C03-8673-71DDDBED2EA1Q56992437-39B3901D-7887-47AD-94AA-EAD8448D33A3
P2860
Electrospun solid dispersions of Maraviroc for rapid intravaginal preexposure prophylaxis of HIV
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@ast
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@en
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@nl
type
label
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@ast
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@en
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@nl
prefLabel
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@ast
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@en
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@nl
P2860
P356
P1476
Electrospun solid dispersions ...... preexposure prophylaxis of HIV
@en
P2093
Cameron Ball
Kim A Woodrow
P2860
P304
P356
10.1128/AAC.02564-14
P407
P577
2014-06-09T00:00:00Z